The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health
Abstract
Potential conflict of interest: Dr. Charlton consults and received grants from Gilead. He consults for Intercept and received grants from GenFit. See Article on Page 73 As far as the scientific community can tell, the first prokaryotic cells emerged on an inhospitable Earth ∼3.8 billion years ago. The first mammalian fossils date to ∼200 million years ago and those of Homo sapiens to a mere 200,000 years ago. The human transition from existence exclusively as hunter‐gatherers to agriculture‐based civilizations began less than 12,000 years ago. Until a blink of an eye ago in biological terms, the ability to find enough food to survive was inconsistent and unpredictable. For several decades we have been producing enough calories at low enough cost for mass overnutrition to occur. Inexpensive grains, especially corn, have translated into inexpensive sugars and, simultaneously, inexpensive animal meat and fat. The US Department of Agriculture's Economic Research Service estimates that caloric intake per capita in the United States is 2700 calories/day, 800 calories/day above that consumed in 1950 (http://www.ers.usda.gov/data‐products/food‐availability‐(per‐capita)‐data‐system/.aspx). The excess of calorie production and consumption is a global phenomenon (Fig. 1). The increase in daily caloric consumption is more than enough to explain the global epidemic of obesity. The most recent analysis by the World Health Organization reports that worldwide obesity has more than doubled since 1980.1 Globally, about 2 billion (39%) adults are overweight and over 600 million (13%) are obese.1 Most of the world's population lives in countries where the consequences of excess nutrition kill more people than undernutrition. The burden of obesity is uneven in geographic terms, with more than half of the world's obese living in just 10 countries.1 In the United States, the most recent National Health and Nutrition Education Survey reports that two‐thirds of adults are overweight or obese and over 1 million individuals have a body mass index >60 kg/m2.2Figure 1: Geographic variation in the daily energy availability per capita (kilocalories) and in the prevalence of NAFLD is shown.In this issue of hepatology Younossi et al.3 present the results of a remarkable study that estimates the global prevalence, incidence, progression, and outcomes of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), bringing together more than 700 individual reports from around the world published between 1989 and 2015. The work has resulted in a new and clearer picture of the worldwide burden of NAFLD and NASH. The results should shape our thinking and approach to fatty liver disease. In a world beset by a litany of critical health challenges, concern about one of the consequences of overnutrition may seem quaint and, probably, transient. The study by Younossi et al. points to a different reality and merits detailed consideration of its three primary conclusions. The global burden of NASH is high, affecting one in four adults, with substantial geographic variation in prevalence. The analysis by Younossi et al. included a sample size of 8,515,431 from 22 countries. The main finding is that the global prevalence of NAFLD is 25.24% (range 22.10%‐28.65%), with the highest prevalence in the Middle East and South America and the lowest in Africa (Fig. 1). Ascertainment and sampling biases may have resulted in this being an overestimate of the prevalence of NAFLD but probably not by much given that the prevalence reported here is consistent with that generated in population studies. An interesting aspect of the report by Younossi et al. is the weak predictivity of the prevalence of obesity and daily caloric excess for the prevalence of NAFLD and NASH, a finding that hints at the importance of factors other than body mass index in the pathophysiology of NAFLD. Genetic susceptibility is an undoubted contributing factor, e.g., to the high prevalence of NASH in Central and South America, where the rs738409 G allele of the PNPLA3 gene is highly prevalent,4 despite much lower daily caloric intake than in North America and western Europe (Fig. 1). Cultural phenomena, such as dietary composition and the prevalence of daily exercise, a strong predictor of NAFLD,5 are also likely to contribute to variation in the geographic prevalence of NASH. With the obvious exception of genetics, almost all of the susceptibility factors for NASH are theoretically modifiable, highlighting the potential impact of education and policy in attenuating the burden of NASH. Fibrosis progression in NAFLD, to the point of liver‐related clinical outcomes, is slow and unusual, with non‐liver‐related mortality being >50‐fold more common than liver‐related mortality for patients with NAFLD. The second compelling observation is that, based on longitudinal analyses, the mean annual rate of progression in NASH is 0.09 fibrosis stages per year (range 0.06‐0.12). With me
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Cited by
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Eslam, M., Valenti, L., & Romeo, S. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.003 · Cited by 971
The multifaceted role of ferroptosis in liver disease
Chen, J., Li, X., Ge, C., Min, J., & Wang, F. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00941-0 · Cited by 665
Epidemiology of non-alcoholic and alcoholic fatty liver diseases
Mitra, S., De, A., & Chowdhury, A. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.09.08 · Cited by 513
Precision Nutrition and the Microbiome, Part I: Current State of the Science
Mills, S., Stanton, C., Lane, J., Smith, G., & Ross, R. (2019) · Nutrients · doi:10.3390/nu11040923 · Cited by 399
Metadata
- Authors
- Rinella, M., & Charlton, M.
- Venue
- Hepatology
- Published
- 2016-04-04
- Volume
- 64
- Issue
- 1
- Pages
- 19-22
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2291276541
- Cited by
- 219
- References
- 2
- FWCI
- 16.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health. https://app.cochat.ai/papers/10.1002/hep.28524
- The paper
- Rinella, M., & Charlton, M. (2016). The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health. Hepatology. https://doi.org/10.1002/hep.28524
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.